|
IFIT5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.519200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.607700E-02 |
| Normal-vs-Stage2 |
8.456400E-01 |
| Normal-vs-Stage3 |
6.681600E-01 |
| Normal-vs-Stage4 |
2.645000E-01 |
| Stage1-vs-Stage2 |
1.511360E-01 |
| Stage1-vs-Stage3 |
1.063830E-03 |
| Stage1-vs-Stage4 |
4.31910000000535E-05 |
| Stage2-vs-Stage3 |
6.095800E-01 |
| Stage2-vs-Stage4 |
3.186800E-01 |
| Stage3-vs-Stage4 |
4.380200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.527600E-01 |
| Normal-vs-AfricanAmerican |
4.209000E-01 |
| Normal-vs-Asian |
8.450600E-01 |
| Caucasian-vs-AfricanAmerican |
5.264000E-02 |
| Caucasian-vs-Asian |
8.201800E-01 |
| AfricanAmerican-vs-Asian |
5.847400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.226200E-01 |
| Normal-vs-Female |
4.621500E-02 |
| Male-vs-Female |
5.717700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.138000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.674400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.370400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.924000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.611600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.461600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.416200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.211400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.506200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.273400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.857200E-03 |
| Normal-vs-Grade 2 |
2.240400E-03 |
| Normal-vs-Grade 3 |
6.334600E-01 |
| Normal-vs-Grade 4 |
2.931900E-02 |
| Grade 1-vs-Grade 2 |
3.159600E-01 |
| Grade 1-vs-Grade 3 |
7.974700E-04 |
| Grade 1-vs-Grade 4 |
3.8201000000071E-05 |
| Grade 2-vs-Grade 3 |
9.5788999998625E-07 |
| Grade 2-vs-Grade 4 |
5.95880000897608E-09 |
| Grade 3-vs-Grade 4 |
2.225800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.198740E-04 |
| Normal-vs-ccB subtype |
3.386800E-01 |
| ccA subtype-vs-ccB subtype |
3.84669962549822E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.525400E-01 |
| Normal-vs-N1 |
2.239600E-01 |
| N0-vs-N1 |
9.165700E-02 |
|
|
